Amphotericin has served as the gold standard for treatment of life-threatening systemic fungal infections for more than half a century, and resistance to this antibiotic remains exceptionally rare. However, amphotericin is also highly toxic, and thus the effective treatment of systemic fungal infections is all too often precluded, nt by a lack of efficacy, but by dose-limiting side effects. Because systemic fungal infections represent a major and growing threat to human health worldwide, a less toxic but equally effective amphotericin derivative stands to have a major impact. Recently, in contrast to the widely accepted channel model, we discovered that amphotericin primarily exerts its activity against yeast and human cells by simply binding ergosterol and cholesterol, respectively. Thus, rather than trying to promote the self-assembly of multimeric ion channels selectively in yeast vs. human cells, efforts toward an improved therapeutic index can now focus directly on the much simpler goal of more selectively binding ergosterol vs. cholesterol. To maximally enable the rational pursuit of this objective, we herein propose to harness the power of organic synthesis to systematically characterize the key structure-function relationships that underlie thi very rare type of small molecule-small molecule interaction. Collectively, these studies will substantially illuminate the fundamental underpinnings of AmB/sterol interactions that are central to the mechanism of action of this clinically vital antifungal agent, generate promising candidates for further development as antifungal agents with an improved therapeutic index, drive the continued development of a highly efficient and flexible building block-based platform for small molecule synthesis, as well as advance site-selective functionalizations as a powerful strategy for accessing targeted derivatives of complex natural products.
Life-threatening fungal infections are a major problem in patients with a compromised immune system, including those undergoing chemotherapy, the elderly, and with AIDS. The best treatment currently available for these infections, amphotericin, is unfortunately also highly toxic. This proposal aims to reduce the toxicity while retaining the powerful antifungal activity of this clinically vital medicine.
|Anderson, Thomas M; Clay, Mary C; Cioffi, Alexander G et al. (2014) Amphotericin forms an extramembranous and fungicidal sterol sponge. Nat Chem Biol 10:400-6|
|Woerly, Eric M; Roy, Jahnabi; Burke, Martin D (2014) Synthesis of most polyene natural product motifs using just 12 building blocks and one coupling reaction. Nat Chem 6:484-91|
|Woerly, Eric M; Miller, Jonathan E; Burke, Martin D (2013) (1-bromovinyl)-MIDA boronate: a readily accessible and highly versatile building block for small molecule synthesis. Tetrahedron 69:|
|Wilcock, Brandon C; Endo, Matthew M; Uno, Brice E et al. (2013) C2'-OH of amphotericin B plays an important role in binding the primary sterol of human cells but not yeast cells. J Am Chem Soc 135:8488-91|
|Dick, Graham R; Woerly, Eric M; Burke, Martin D (2012) A general solution for the 2-pyridyl problem. Angew Chem Int Ed Engl 51:2667-72|
|Gray, Kaitlyn C; Palacios, Daniel S; Dailey, Ian et al. (2012) Amphotericin primarily kills yeast by simply binding ergosterol. Proc Natl Acad Sci U S A 109:2234-9|
|Palacios, Daniel S; Dailey, Ian; Siebert, David M et al. (2011) Synthesis-enabled functional group deletions reveal key underpinnings of amphotericin B ion channel and antifungal activities. Proc Natl Acad Sci U S A 108:6733-8|
|Lee, Suk Joong; Anderson, Thomas M; Burke, Martin D (2010) A simple and general platform for generating stereochemically complex polyene frameworks by iterative cross-coupling. Angew Chem Int Ed Engl 49:8860-3|
|Lee, Suk Joong; Gray, Kaitlyn C; Paek, James S et al. (2008) Simple, efficient, and modular syntheses of polyene natural products via iterative cross-coupling. J Am Chem Soc 130:466-8|
|Palacios, Daniel S; Anderson, Thomas M; Burke, Martin D (2007) A post-PKS oxidation of the amphotericin B skeleton predicted to be critical for channel formation is not required for potent antifungal activity. J Am Chem Soc 129:13804-5|